Olanzapine concentrations collected postmortem in patients treated with olanzapine long-acting injection

被引：1
|
作者：
McDonnell, D. P. [1 ]
Detke, H. C. [1 ]
Falk, M. [1 ]
Shatapathy, C. C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70776-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.053
引用
收藏
页码：S489 / S490
页数：2
相关论文
共 50 条
  • [1] Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation
    Baldelli, Sara
    Mauri, Massimo C.
    Di Pace, Chiara
    Paletta, Silvia
    Reggiori, Alessandra
    Rovera, Chiara
    Clementi, Emilio
    Cattaneo, Dario
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 365 - 369
  • [2] Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
    Heres, Stephan
    Kraemer, Susanne
    Bergstrom, Richard F.
    Detke, Holland C.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 299 - 312
  • [3] Olanzapine long-acting injection: Pharmacokinetic and dose correspondence data relative to oral olanzapine
    Gulliver, A.
    Detke, H. C.
    McDonnell, D. P.
    Bergstrom, R. F.
    Lin, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 152 - 153
  • [4] Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching
    Detke, Holland C.
    Zhao, Fangyi
    Garhyan, Parag
    Carlson, Janice
    McDonnell, David
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (01) : 35 - 42
  • [5] Comparison of outcomes in patients with early versus later phase schizophrenia treated with olanzapine long-acting injection
    Detke, H.
    Correll, C.
    Liu, C.
    Landry, J.
    Feldman, P.
    McDonnell, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 114 - 114
  • [6] Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
    Di Lorenzo, Rosaria
    Brogli, Alice
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 573 - 581
  • [7] Postinjection syndrome occurred in 1.75% of patients following olanzapine long-acting injection
    Reactions Weekly, 2010, 1306 (1) : 5 - 5
  • [8] A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
    Atkins, Susan
    Detke, Holland C.
    McDonnell, David P.
    Case, Michael G.
    Wang, Shufang
    BMC PSYCHIATRY, 2014, 14
  • [9] A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
    Susan Atkins
    Holland C Detke
    David P McDonnell
    Michael G Case
    Shufang Wang
    BMC Psychiatry, 14
  • [10] Injection-related adverse events observed with olanzapine long-acting injection
    Gulliver, A.
    McDonnell, D. P.
    Sorsaburu, S.
    Brunner, E.
    Detke, H. C.
    Andersen, S. W.
    Bergstrom, R. F.
    Mitchell, M.
    Ogle, K.
    Stickelmeyer, M. P.
    Corya, S. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 152 - 152
12345